文献速递耳科与耳神经

后半规管良性阵发性位置性眩晕眼震的定量分析及其与预后的关联

Quantitative Analysis of the Nystagmus of Posterior Canal Benign Paroxysmal Positional Vertigo and Its Association With Prognosis.
PubMed 文献 · Ear Hear · 2026-02-23

该前瞻性研究纳入285例后半规管BPPV患者,在三维旋转椅上用红外视频眼动仪记录位置性眼震,分析其方向、潜伏期和持续时间与治疗结局的关系。结果显示Dix-Hallpike试验诱发的眼震潜伏期和持续时间预后价值有限,而改良Epley手法第三位置的眼震与治疗成功相关。

要点

  • Dix-Hallpike试验眼震潜伏期与持续时间对BPPV预后价值有限。
  • 改良Epley手法第三位置眼震是治疗成功的阳性预测因素。
  • 难治性病例采用360°旋转复位是可行的替代方案。

核心结论

  • Dix-Hallpike试验诱发的位置性眼震潜伏期和持续时间在BPPV中预后价值有限。
  • 改良Epley手法第三位置的眼震与治疗成功相关。
  • 对难治性病例,基于旋转椅的360°旋转是有前景的替代治疗。

研究设计与样本

  • 前瞻性研究,最终分析纳入285例后半规管BPPV患者。
  • 患者在三维旋转椅上接受位置试验和手法复位,全程用红外视频眼动仪记录眼震。
  • 以改良Epley手法为主要治疗,无效者以360°旋转作为补救治疗。

主要发现

  • Dix-Hallpike试验头悬位眼震潜伏期中位数为0.47秒(IQR 0–1.3),坐起位为0秒(IQR 0–0.7)。
  • 头悬位和坐起位眼震持续时间中位数分别为12.7秒(IQR 9.7–16.7)和13.6秒(IQR 9.1–18.8)。
  • 98例(34.4%)患者未观察到潜伏期,但不影响治疗成功率(p=0.15)。
  • 症状严重程度与眼震持续时间正相关(p=0.003)。
  • 改良Epley手法第三位置的扭转上跳性眼震是治疗成功的阳性预测因素(73.0% vs 44.8%;p<0.001)。

关键数值与推荐

  • 改良Epley手法第四位置的扭转下跳性眼震与治疗疗效无关(68.3% vs 62.1%;p=0.27)。
  • 40例接受360°旋转的难治性患者中,24例(60.0%)在7至14天内完全缓解。
  • 初始治疗当天成功与7至14天时缓解率或残余头晕无关。

临床怎么用

  • 临床可依据改良Epley手法第三位置眼震预判后半规管BPPV的治疗反应。
  • 对Epley手法无效的难治性病例可考虑360°旋转复位。
  • 治疗后仍有残余眼震的患者在7至14天结局与无残余眼震者相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Positional nystagmus triggered by a change of head position is essential for the diagnosis and treatment of benign paroxysmal positional vertigo (BPPV). However, the quantitative data on its characteristics and prognostic value remain unclear. The objective of this study is to quantify the direction, latency, and duration of positional nystagmus in posterior canal BPPV and explore their association with treatment outcomes. DESIGN: Patients diagnosed with posterior canal BPPV were enrolled prospectively. Participants underwent positional tests and canalith repositioning procedures on a multiaxial repositioning chair with infrared video-oculography. Positional nystagmus was recorded throughout diagnosis and treatment. Modified Epley maneuver with repositioning chair was the primary treatment. For patients unresponsive to Epley maneuvers, 360° rotation was the salvage treatment. Outcomes include resolution of positional nystagmus and subjective severity of symptoms assessed by a visual analogue scale. RESULTS: A total of 285 participants were included in the final analysis. The median latency of nystagmus was 0.47 (interquartile range [IQR]: 0 to 1.3) seconds in head-hanging position of Dix-Hallpike test and 0 (IQR: 0 to 0.7) seconds in the sitting-up position, with median durations of 12.7 (IQR: 9.7 to 16.7) and 13.6 (IQR: 9.1 to 18.8) seconds, respectively. No latency was observed in 98 (34.4%) participants, but this did not affect the rate of treatment success ( p = 0.15). The severity of symptoms was positively correlated with nystagmus duration ( p = 0.003). Torsional, up-beating nystagmus in the third position of the modified Epley maneuver was a positive predictor of a successful treatment (73.0% versus 44.8%; p < 0.001), whereas torsional, down-beating nystagmus in the fourth position was not associated with treatment efficacy (68.3% versus 62.1%; p = 0.27). For refractory cases, 24 (60.0%) of 40 patients who received 360° rotation had complete resolution in 7 to 14 days. Unexpectedly, initial treatment success on day 0 was not associated with the rate of resolution or residual dizziness at 7 to 14 days. CONCLUSIONS: The latency and duration of the positional nystagmus elicited by Dix-Hallpike test had limited prognostic value in BPPV, whereas in the modified Epley maneuver, nystagmus in the third position was associated with treatment success. For refractory cases, chair-based 360° rotation is a promising alternative. Patients with residual nystagmus after treatment had comparable outcomes to those without at 7 to 14 days.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Yu F, Zhao J, Yu J, et al. Quantitative Analysis of the Nystagmus of Posterior Canal Benign Paroxysmal Positional Vertigo and Its Association With Prognosis. Ear Hear. 2026. PMID: 41730076. doi:10.1097/AUD.0000000000001795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。